EU đặt mua 220.000 liệu trình điều trị COVID-19 của GlaxoSmithKline
Ngày 28/7, Liên minh châu Âu (EU) cho biết đã ký một thỏa thuận với công ty dược phẩm GlaxoSmithKline của Anh về việc cung cấp lên đến 220.000 liệu trình thuốc Sotrovimab điều trị bệnh nhân COVID-19 bằng kháng thể đơn dòng mà hãng này đang phát triển. GlaxoSmithKline cùng ngày cũng đã xác nhận thỏa thuận này.
e8OtMzHEkW7DoHV1JTByw5rDrMO6buG6uTB94bq4w5kxw6nhurXDujFvw7nDoDE0NDIoMjIyMW7DrOG7hcO5McO6dOG7icOzw60xw6nDrOG7g8O5McO6dMSpMcSQw5JYw4xFLTPDoTHEkcaww6AxSW7DoMO9w7JVb8Osw7rDrU1uw6zDs+G6uXsvw60zfXtyMcSRbsOgdXUlMHLDjeG6ucOgZTB9w5Np4bqj4buzMTRhLzkhMU7DrOG7gcOzMW/DrMOzw60xxJHDreG6p8O5MeG6psO5MTzhurjDmT4xxJHDrcOyMWTDrOG7h8O6McOp4bqvMW3hu7Uxb+G7l8O6McO6w63DtMOgMcO6w63DueG6q8OzMXjhu6PDrDHEkeG7k8OzaTHDuuG7szFl4bur4buhxJExcsOtYm8xSW7DoMO9w7JVb8Osw7rDrU1uw6zDs+G6uTHEkcaww6Axw4DDs8OtMXjhu4MxeMOs4buFxJExxJHDucOzaTHEkeG6rXIxbuG7gcOzMcOp4buHw7MxNDQyKDIyMjFuw6zhu4XDuTHDunThu4nDs8OtMcO6w63DueG7mcSRMVXDssO6dMOyeMOsb8OgZDHDqcOs4buDw7kxw7p0xKkxZOG7hcOzw60xw7PDreG6p8OzMcSQw5JYw4xFLTPDoTFk4bqzw7NpMW3DreG6ocOzaTHDusOtZjHDqeG7ncOzMWXhu4/Ds2kxb+G6ozHDreG6r8OzaTHDs+G6o+G7szHDqcOgw7NpMXLDreG6ocO6McO6dMOsZsOzKDFJbsOgw73DslVvw6zDusOtTW7DrMOz4bq5McSR4bunw7NpMcOzaeG6o+G7szHEkeG7qcOzaTHDqeG6rzHDveG6ocSRMcOzw63huqvDszHDusOtw7TDoDHDusOtw7nhuqvDszHDs+G6o+G7syh7L3J9e3IxxJFuw6B1dSUwckTDsmXhu7MwfXvDrG9pMcSRbsOgdXUlMMSRb3UtcsOtw7LDusOyMDHDusOsw7pu4bq5JTDhurjDmTHDqeG6tcO6MW/DucOgMTQ0MigyMjIxbsOs4buFw7kxw7p04buJw7PDrTHDqcOs4buDw7kxw7p0xKkxxJDDkljDjEUtM8OhMcSRxrDDoDFJbsOgw73DslVvw6zDusOtTW7DrMOz4bq5McOt4buJw7PDrTHEg8Ozw60xMzAxdXTEkSUwLy/EkShkw6DDssO6w63DoMOzw63DrcOyw6AoeMOzL8Osb2kvZeG6uXVtw7rDsnIvw7Phurl5dS80MzUyLzM5OWU2MmE2OTc2w7rDoTQ3bjMoeeG6uWRyMDHDoG7DuiUw4bq4w5kxw6nhurXDujFvw7nDoDE0NDIoMjIyMW7DrOG7hcO5McO6dOG7icOzw60xw6nDrOG7g8O5McO6dMSpMcSQw5JYw4xFLTPDoTHEkcaww6AxSW7DoMO9w7JVb8Osw7rDrU1uw6zDs+G6uTAxZcOgw7rDoC1yw63DssO6w7Itw7J0w6xpw6zDs8Ogbi11dMSRJTDDrcO6w7pydSwvL8SRZcOzw6xvaSh4w6zhurnDusOzw6Bvcm7DuXUoeMOzL8O6ODQyL8O5cm7DssOgZeG6uWUvZMOybcO6w7psLzQyNDNfMjlfNGEvw7rDusO9eMOzX23DrcOgw7NpX8O6w63hurlfxJHDsnjDrGUzw6EobHJpMDEvfU7DrOG7hcO5MXLDreG6oXIxw6nDrOG7g8O5McO6dMSpMW3DreG6ocOzaTHDusOtZjFVw7LDunTDsnjDrG/DoGQxxJHDrcOyMWThu4XDs8OtMcOzw63huqfDszHEkMOSWMOMRS0zw6EhMWXDsjHEkOG7k8OzaTHDuuG7szFl4bur4buhxJExSW7DoMO9w7JVb8Osw7rDrU1uw6zDs+G6uTE8w4DDs8OtPjF44bqjMcSQ4buTw7NpMcO64buzMVjDrHQxRMOsw7LDuuG6ucSRw63Ds8OybsOyaeG7szE8T8OBPjF1xIPDszHDvcO54bqtw7ooMTzEgsOzw60sMcOaw63hurkxw5PDoMO6w6zDssOzw6BuL8Oaw5rDnVjDkz57L3J9e3IxxJFuw6B1dSUwckTDsmXhu7MwfcOaw63hurnDsjHhurjDmSExw7rDrcO54buZxJExVcOyw7p0w7J4w6xvw6BkITFlw7IxSW7DoMO9w7JVb8Osw7rDrU1uw6zDs+G6uTFyw63hu5nDrDHDreG7oXIxeOG7o8OsMcSR4buTw7NpMcO64buzMcSR4buTw7NpMcOzacOt4buFMXXDrMOzw60xw63DtcSRMVjDrHQxRMOsw7LDuuG6ucSRw63Ds8OybsOyaeG7szHEkcaww6AxT8OBMcOzacOtw6zhu4HDszHEkeG7scO5MXjhuqMxcsOt4bqhw7oxw7p0w6xmw7MhMcSR4buNMcO6w61mMXV2MWXFqcOzaTHDqWYxw6nDrOG7g8O5McO6dMSpMWThu4XDs8OtMcOzw63huqfDszHEkMOSWMOMRS0zw6ExxJHhu40xw7p0w6zhu4XDuTHEkcOt4buxw7NpMcOzw63hur0hMW3DreG7k8OzaTHEkeG6qcOzMcO6w61wMcOyw73hu7MhMcOzw63hu6vDs2kxxJHhu40xw7Npw7nhu7MxxJHhu50xZcOsZ8OzMWTDrOG7h8OzMWThu4XDs8OtMcOz4bq1w7NpMcOt4budw7Moey9yfXtyMcSRbsOgdXUlMHJEw7Jl4buzMH3DjcOs4buFw7MxxJDhu50xc8O5w6DDszFTw7nEg8OzMW7hu7UxZeG7q+G7ocSRMXLDrWJvMcSRw63huqfDuTHhuqbDuTE84bq4T8OAPjHDqcOgw7NpMcO6w6zhu4fDszHDreG6o8Ozw60xw6nhuqHDs8OtMWnDrOG6oTHDuuG7i8Ozw60xw63DrOG7hcO5MXPDucSDMcSRxrDDoDFuw7LDo8OsMcO6w63DueG7mcSRMcOz4bqj4buzKHsvcn17cjHEkW7DoHV1JTByRMOyZeG7szB9w5p04bur4bujxJExw6nhu40hMU/DgTHEkeG7qcOzaTHDqeG6rzHEkeG6rXIxcsOt4bq7cjF1djFlxanDs2kxbcOtYsOzMcSR4bqtcjHDusOtw7nhu5nEkTFVw7LDunTDsnjDrG/DoGQxw6lmMcOpw6zhu4PDuTHDunTEqTFk4buFw7PDrTHDs8Ot4bqnw7MxxJDDkljDjEUtM8OhMXAxw7rDrWYxw7PDreG6vTHDqeG7h8OzMcO6dMO5w7NpMWThu4nDs8OtMXjhuqMxxJHhu40xw7Npw7nhu7MxxJHhu50xxJHDrcO54buzZsOzMWTDrOG7h8OzMcOz4bq1w7NpMcOt4budw7Moey9yfXtyMcSRbsOgdXUlMHJEw7Jl4buzMH3DmsOtw7TDoDHDusOtw7nhuqvDszHDunThu4HDszHDqeG7q+G7ocSRMTM4LzQ5MXPDueG7mcSRMWnDrMOgMcO6w63huqPDs8OtMXjDrOG7gcOzMeG6uMOZMcaww7NpMcOt4buXITHDs8Otd8OzaTHDs+G7q+G7o8SRMcSRw61qMcSR4buNMcO6w61mMW/DucOgMcO6w63DueG7mcSRMVXDssO6dMOyeMOsb8OgZDF1w6DDuTFtw63DrDHDqeG7q+G7ocSRMeG6uE/DgDHDrcOy4bq1xJExxJHhu50xc8O5w6DDszFzw7nEg8OzMW7hu7UxZeG7q+G7ocSRMXLDrWJvMXPDueG7mcSRMWnDrMOgMcSRw63DsjFyw63hurtyMW7hu6vDuTHDreG6o8Ozw60oMUnDrOG6oTHDunTEqTHDreG7oXIxw6nhu5XDs2kxw63DrOG7hcOzMcSRw63hu6vDoDHDqeG7q+G7ocSRMcO6w63hu5PDs2kxZOG6ocOyKHsvcn17cjHEkW7DoHV1JTByRMOyZeG7szB9w5p04bur4bujxJExw6nhu40hMcO6w63huqHDs2kxNjF44butw6Axc8O5w6AhMeG6uMOZMcSR4bupw7NpMcOp4bqvMW3hu7Uxb+G7l8O6McO6w63DtMOgMcO6w63DueG6q8OzMcO64bur4budw7NpMcO64buvMXjhu6PDrDHEkeG7k8OzaTHDuuG7szFl4bur4buhxJExcsOtYm8xVMOyxJHDreG6uTHEkcaww6Axw5rDrcWp4buzMVVrMXjhu4MxeMOs4buFxJExw6nhurXDujFvw7nDoDE3NygyMjIxbsOs4buDw7kxw7rDrcO54buZxJExw6nDrOG7g8O5McO6dMSpMWThu4XDs8OtMcOzw63huqfDszHEkMOSWMOMRS0zw6ExZOG6s8OzaTFtw63huqHDs2kxw7rDrWYxw6nhu53DszFl4buPw7NpMcO6w6zhu4NvMcOz4bqxw7NpMWXDsjHDreG6r8OzaTHDs+G6o+G7szFyw63hu5nDrDHDreG7oXIxeOG7o8OsMcSR4buTw7NpMcO64buzMWXhu6vhu6HEkTFyw61ibzFU4bq5aeG6ucOz4bq5dMOyw7MxxJHGsMOgMU/DgTFyw63huqHDujHDunTDrGbDsyh7L3J9e3IxxJFuw6B1dSUwckTDsmXhu7MwfcOJ4buHw7Mxw7PDoOG7syExw7Npw7LhuqPDrDFuw6zhu4XDuTFyw63huqFyMcOpw6zhu4PDuTHDunTEqTFk4bqzw7NpMW3DreG6ocOzaTHDusOtZjHDqeG7ncOzMWXhu4/Ds2khMeG6uMOZMcSRw61qMXV2MWXFqcOzaTFlw7nhu7Mxw7PDreG6rcO6MW/hu5fDujFuw7LDo8OsMcO6w63DueG7mcSRMcSRw63hu5nDs2kxxJDDkljDjEUtM8OhMcOp4bqvMW/DucOgMW7huqMxVOG6uW9l4bq5dcOseMOsdDHEkcaww6Axw63huq/Ds2kxScOsbuG6ucOgZSExb+G7l8O6MW7DssOjw6wxw7rDrcO54buZxJExbcOt4bqhw7NpMXjDrHTDuXUoey9yfXtyMcSRbsOgdXUlMHJEw7Jl4buzMH3Dk+G6sW8xw7Npw7LhuqHDrCEx4bq4w5kxw6nhuq8xw6nhurXDujFvw7nDoDE3MjIoMjIyMW7DrOG7hcO5McO6dOG7icOzw60xw7rDrcO54buZxJExVOG6uW9l4bq5dcOseMOsdDF1w6DDuTFtw63DrDHEkeG6rXIxcsOt4bq7cjF1djFlxanDs2kxbsOyw6PDrDHDusOtw7nhu5nEkTHDs+G6o+G7sygvKHsvcn17cjHEkW7DoHV1JTByw4DDucO6w63DsnQwfTzDmsOaw51Yw5MvWMOs4bq5w7rDs8Ogbys+ey9yfQ==
Bình luận
Xin vui lòng gõ tiếng Việt có dấu